Table 2. Recurrence rates at 10 years and ‘time lost to recurrence’ in first 10 years (%) assuming no intercurrent mortality for four different treatment strategies and either a 2 year or 5 year carryover effect.

		Recurrence(%)				Time lost (%)
	Carryover (years)	Initial AI	Tam 2 years + AI 3 years	Tam 5 years + AI 5 years	Tam 5 years	Initial AI	Tam 2 years + AI 3 years	Tam 5 years + AI 5 years	Tam 5 years
All ER+	2	18.9	19.2	18.9	22.9	9.3	9.9	11	12.1
	5	17.3	17.1	18.9	22.9	9	9.6	11	12.1
ER+/PgR−	2	21.9	25.5	25.8	34	9.4	13.2	16.3	18.4
	5	16.3	20.2	25.8	34	8.5	12.3	16.3	18.4
ER+/PgR+	2	16	15	15	17.8	7.7	7.3	8.2	9
	5	15.2	13.2	15	17.8	7.6	7.1	8.2	9
Deep model	2	20.3	21.3	21.2	24.5	9.6	10.5	11.6	12.5
(20% PgR−)	5	18.1	19.1	21.2	24.5	9.2	10.2	11.6	12.5